Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-27 @ 12:38 AM
Study NCT ID:
NCT00134251
Status:
COMPLETED
Last Update Posted:
2009-01-30
First Post:
2005-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
Sponsor:
Solvay Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
S308.3.005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None